Beam Therapeutics Inc

NASDAQ:BEAM   3:59:59 PM EDT
36.07
+3.51 (+10.78%)
Earnings Announcements

Beam Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/09/2022 13:44 GMT
Beam Therapeutics Inc (BEAM) - Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $1.01.
Ended Q1 2022 With $1.2 Billion in Cash, Cash Equivalents and Marketable Securities.
Q1 Earnings per Share View $-1.32 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $8.39 Million
Adjusted EPS is expected to be -$1.09

Next Quarter Revenue Guidance is expected to be $6.06 Million
Next Quarter EPS Guidance is expected to be -$1.15

More details on our Analysts Page.